Era Mandiri Cemerlang Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp84 (market cap 70.83B, 22.67M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 157.8× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (22.67M versus 613K). Which is the better fit depends on your goals.
| IKAN | TSPC | |
|---|---|---|
Market Cap | 70.83B | 11.18T |
Volume | 22.67M | 613K |
Lot | 226.74K | 6.13K |
Turnover | 1.96B | 1.54B |
Average Price | 86.4 | 2,511.52 |
Value | 1.96B | 1.54B |
Indicative Equilibrium Price | 84 | 2,520 |
Indicative Equilibrium Volume | 6.44K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →